Omran Abu Aboud - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Kidney International|May 27, 2017

Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney diseaseVicki J Hwang, Xia Zhou, Xiaonan Chen, et al.

Oncotarget|August 31, 2016

Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancerJosephine F Trott, Jeffrey Kim, Omran Abu Aboud, et al.

Cancer Research|May 9, 2015

Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics AnalysisHiromi I Wettersten, A Ari Hakimi, Dexter Morin, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Kidney International|May 27, 2017

Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney diseaseVicki J Hwang, Xia Zhou, Xiaonan Chen, et al.

Oncotarget|August 31, 2016

Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancerJosephine F Trott, Jeffrey Kim, Omran Abu Aboud, et al.

Cancer Research|May 9, 2015

Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics AnalysisHiromi I Wettersten, A Ari Hakimi, Dexter Morin, et al.

Pageof 2